A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Minocycline (AMZEEQ)

Tetracycline-class Drug class · 11 generic manufacturers · 53 ANDAs filed at FDA.

First FDA approval1992-02-01
Generic availableYes · 11 mfrs
Shortage statusDiscontinued
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$15.9M in CY2024 Part D spend522K claims · 257K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.175/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.310
Across all dosage forms in distribution.
Highest NADAC
$0.383
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema12 entries indexed · 4 visible
What is Minocycline used for?

Minocycline is a Tetracycline-class Drug medication tracked in Medicare Part D.

Is there a generic for Minocycline?

Yes. 53 ANDAs filed at FDA, 11 generic manufacturers currently shipping.

How much does my plan pay for Minocycline?

Across 329 Part D plans, Minocycline averages $0.310/unit (NADAC). Lowest available: $0.175/unit. Highest in distribution: $0.383/unit.

Is Minocycline on the FDA shortage list?

Minocycline has been discontinued by its manufacturer(s).

8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Tetracycline-class Drug2 alternatives in D1
01
Doxycycline
Brand: Doxy 100
$0.115Lowest NADAC
15Generic mfrs
$4,756CY24 Part D spend
Compare →
02
Doxycycline Hyclate
Brand: Acticlate
$0.094Lowest NADAC
34Generic mfrs
$131.1MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.